NEWS

DKD’s News page serves as a journal of research, application, and professional connection: clinical reports, workshops and training sessions, collaborations with hospitals and academic institutions, technology testing and transfer, as well as community programs. Here, we share representative case studies, scientific publications and whitepapers, patents, and international events—creating opportunities for collaboration among clinicians, researchers, and industry partners.

DKD participated in the CRS BioBarriers conference and presented an international research poster

DKD took part in the CRS BioBarriers event in Saarbrücken, connecting with the international scientific community in the fields of drug delivery, biological barriers, and phospholipid technology. At the conference, DKD presented a research poster on green extraction of egg-yolk phospholipids, together with a nanocurcumin system with preliminary application for rare epithelial injuries.

Saarbrücken, Germany — March 5, 2026

DKD Founder was honored among the Top 5 Inventive Authors
at the IPSTAR 2025 program

At the 10th anniversary ceremony of the Vietnam Inventors Association, DKD Founder – Dao Thi Kim Dung – was honored as one of the Top 5 outstanding inventive authors at IPSTAR 2025. The event took place in the context of Vietnam moving toward Techfest 2025 and the spirit of innovation under Resolution 57-NQ/TW, further highlighting the role of intellectual property in the development of science and technology.

Ho Chi Minh City, Vietnam — November 22, 2025

DKD’s burn treatment product applied for children:
A physician from Children’s Hospital 1 shared real clinical cases at the National Scientific Conference

At the National Scientific Conference in Hue, Dr. Le Huu Phuoc (Children’s Hospital 1) shared a clinical case series using DKD’s biological gel for burns, ulcers, and post-surgical reconstructive care. Representative outcomes included: Fournier wound healing in about 10 days; SJS re-epithelialization in 3 days; ulcerative hemangioma closure after more than 1 month; and a dry Snodgrass surgical wound with no leakage after 11 days.

Hue City, Vietnam — May 24, 2025

DKD introduced the SUV Liposome biological membrane – PL Pro at the workshop “Care for hard-to-heal wounds” in Khanh Hoa

DKD collaborated with Khanh Hoa General Hospital to organize the thematic workshop “Care for hard-to-heal wounds: solutions and current realities” in order to update medical staff on non-invasive treatment approaches. At the event, DKD introduced PL Pro – a biological cell-membrane preparation with SUV Liposome structure, offering a solution for cleansing and protecting the wound surface, creating a physiological moist environment favorable for healing, and being easily applied both in hospitals and in the community.

Nha Trang City, Vietnam — August 30, 2024

DKD attended ISBI/BBA 2024
A global gateway for Vietnam’s wound-healing solutions

DKD was the only representative from Vietnam attending the ISBI 2024 Conference (International Society for Burn Injuries), an event gathering more than 1,000 leading global experts in burn care and tissue regeneration. The conference aimed to share knowledge and promote humane, sustainable, and advanced treatment solutions for patient communities worldwide.

Birmingham, United Kingdom — August 18–22, 2024

DKD published its first scientific paper:
Nanocurcumin liposome & PL Pro promote healing of burns and skin ulcers

DKD’s first paper in The Open Dermatology Journal presented preclinical data showing that liposomal nanocurcumin and PL Pro nanocurcumin helped reduce wound area, increase hydroxyproline, and improve histological outcomes in thermal burn and skin ulcer models, while remaining safe for topical application. This marked an important milestone in DKD’s R&D journey, opening opportunities for collaboration and multicenter research under international standards.

July 7, 2024

DKD reported the application of PL Pro biological gel for burn treatment at the Le Huu Trac National Burn Hospital

Representatives of the DKD Institute for Research & Application of Biological Excipients delivered a thematic presentation at the Le Huu Trac National Burn Hospital, focusing on practical experience in using PL Pro biological gel for the care of deep burns, necrotic burns, and chronic non-healing ulcers. The event attracted a large number of physicians, nurses, and medical specialists from different departments, creating an open and clinically rich academic exchange.

Hanoi, Vietnam — April 22, 2024

DKD participated in the CRS BioBarriers conference and presented an international research poster

In 2026, DKD had the opportunity to attend the international scientific conference CRS BioBarriers in Saarbrücken, Germany – one of the important academic forums bringing together leading scientists, specialists, and research organizations in the fields of drug delivery, biological barriers, and lipid technology.

The event was not only a place for exchanging knowledge but also opened valuable connections among research groups worldwide, especially in the context of biological technologies increasingly moving toward sustainability, biocompatibility, and personalized treatment.

At the conference, DKD representatives presented a research poster entitled:

“Green Extraction of Egg-Yolk Phospholipids and Nano Curcumin System with Preliminary Evaluation in Epidermolysis Bullosa”

The study focused on developing a “green” extraction method for egg-yolk phospholipids with the support of biological enzymes, aiming to replace conventional processes that rely on organic solvents.

Based on the phospholipid excipient obtained, DKD further developed a nano curcumin delivery system directed toward wound care applications, particularly for difficult-to-heal epithelial injuries.

Preliminary observations suggested the potential of the phospholipid–nano curcumin system in supporting tissue regeneration, improving the wound microenvironment, and contributing to future research directions for rare diseases such as Epidermolysis Bullosa (EB).

During the conference, DKD also had the opportunity to meet and exchange ideas directly with Dr. Simon Drescher – Managing Director of the Phospholipid Research Center and Secretary-in-Chief of the CRS DeChAt Local Chapter.

These in-depth discussions on the structure, physicochemical properties, and application potential of phospholipids provided valuable perspectives, helping shape DKD’s next research directions in the development of next-generation biological excipients.

In addition, DKD had the chance to meet young researchers and doctoral students from Vietnam who are currently studying and working in Europe.

Moments like these carry not only personal meaning, but also inspire a strong sense of hope that Vietnamese scientists are becoming increasingly visible within the global research community.

Cross-border collaboration will continue to open new opportunities for science and technology in the future, while enabling research initiatives from Vietnam to connect more deeply with the world.

The CRS BioBarriers conference was not only an academic event, but also an important milestone in DKD’s journey to bring its biological phospholipid technology to the world – step by step connecting, learning, and contributing to the global scientific ecosystem.

DKD Founder was honored among the Top 5 Inventive Authors at IPSTAR 2025

Ho Chi Minh City, 22/11/2025 – DKD Founder, Ms. Dao Thi Kim Dung, was honored among the Top 5 inventive authors in the IPSTAR 2025 program, an important event marking the 10th anniversary of the Vietnam Inventors Association.

Significance of the event

IPSTAR 2025 is a program that honors individuals with outstanding contributions to invention, intellectual property, and technological innovation. This was the first time the Vietnam Inventors Association held a national-scale recognition ceremony, at a time when Vietnam is promoting its innovation ecosystem toward Techfest 2025 and implementing Resolution 57-NQ/TW on breakthroughs in science, technology, and digital transformation.

DKD’s patent achievements

The recognition of DKD’s founder among the Top 5 at IPSTAR 2025 reflects her persistent journey in developing two U.S. patents – the foundation for DKD’s core technologies in biological excipients, tissue regeneration, and next-generation drug delivery systems.

Intellectual property as a driver of domestic technology development

IPSTAR 2025 emphasized the central role of intellectual property in fostering innovation, creating application value, and enhancing national competitiveness. For DKD, this is not only recognition, but also a strong motivation to continue expanding its patent ecosystem, accelerating commercialization, and affirming the position of “Made in Vietnam” biotechnology.

“This honor is not only for an individual, but for DKD’s entire effort to bring Vietnamese science closer to international standards, using intellectual property as the foundation for developing products that truly serve the community.”

DKD will continue pursuing biopharmaceutical research, developing tissue regeneration technologies, and fostering domestic and international multicenter collaborations, contributing to bringing Vietnamese innovation to the global stage.

DKD’s burn treatment product in clinical practice:
A physician from Children’s Hospital 1 shared real cases at the national scientific conference

At the national conference (Hue, 5/2025), Dr. Le Huu Phuoc presented a series of clinical cases using DKD biological gel for deep burns, ulcers, and post-reconstructive surgery care.

Remarkable results included: complete healing of Fournier wound after hypospadias surgery in more than 10 days; improved re-epithelialization in Stevens–Johnson syndrome within 3 days; closure of ulcerative hemangioma after more than 1 month; and a dry Snodgrass surgical wound with no leakage after 11 days.

Dr. Phuoc emphasized that this is “a modern wound-management solution,” easy to use, prescription-free, suitable for children and mucosal areas — opening a direction for non-invasive care in the community.

Context & presenter

At the 15th National Scientific Conference on burns, wound healing, plastic and reconstructive surgery, held at Hue Central Hospital (5/2025), Dr. Le Huu Phuoc (Children’s Hospital 1) presented real-world experience using PL Pro biological gel in clinical treatment. The presentation was based on actual patient cases, staged recovery images, and specific care protocols.

Representative clinical cases

Fournier after hypospadias surgery (pediatric): Treated with PL Pro, with complete healing after more than 10 days.
Stevens–Johnson syndrome (SJS): Re-epithelialization improved markedly after 3 days of gel application.
Ulcerative hemangioma without surgical indication: The ulcer closed after more than 1 month of home care.
Post-urethroplasty (Snodgrass): The surgical wound remained dry, without exudate or urine leakage after 11 days.

“I do not call this a drug – I call it a modern wound-management solution that can replace folk treatment habits with a product grounded in science, easy to use, clearly effective, and harmless.” — Dr. Le Huu Phuoc

Practical significance

With its accessibility, prescription-free use, and suitability for both children and sensitive mucosal areas, PL Pro opens up a non-invasive wound treatment approach in the community, especially under resource-limited conditions.

“One image is worth more than a thousand words” — the clinical evidence and recovery photographs form the foundation for confidence in the real effectiveness of PL Pro in burn care, ulcer management, and post-reconstructive situations.

DKD introduced the SUV Liposome biological membrane – PL Pro at the workshop “Care for hard-to-heal wounds” in Khanh Hoa

Khanh Hoa, 30/08/2024 – With support from burn and wound-care specialists in Ho Chi Minh City and the leadership of Khanh Hoa General Hospital, DKD introduced the biological cell-membrane preparation with SUV Liposome structure – PL Pro – at the workshop “Care for hard-to-heal wounds: solutions and current realities,” held directly at the hospital.

The workshop attracted more than 250 participants, including physicians, nurses, and healthcare managers. At the event, specialists from the Burn and Plastic Surgery Department of Children’s Hospital 1 in Ho Chi Minh City provided an overview of the realities and causes of delayed wound healing, while also presenting non-invasive treatment approaches using biological membrane preparations.

The application section focused on PL Pro (a topical gel based on SUV Liposome biological membrane), illustrated by a series of real clinical cases and care protocols both in healthcare settings and at home.

Improper wound care can result in serious sequelae and complications, as well as significant pain and treatment costs for patients. In this context, the SUV Liposome biological membrane solution – PL Pro – was introduced as a new approach that helps:

Support cleansing and protection of the wound surface, creating a physiological moist environment favorable for healing.
Be applicable to various clinical situations: burns, chronic ulcers, post-reconstructive surgery care, and sensitive skin or mucosal areas.
Remain accessible and easy to use, suitable for community application where intensive care conditions are limited.

During the discussion session, participants raised questions about indications and contraindications, care pathways, the possibility of combining with specialized dressings, and remote monitoring for outpatients. The professional team provided guidance on application, progression monitoring criteria, and standards for evaluating effectiveness and safety at each stage of wound healing.

Ms. Kim Dung (center) – DKD Founder together with professors, physicians, and partners.

The leadership of Khanh Hoa General Hospital and DKD expect that through this workshop, practical knowledge will be updated for the medical staff, improving the quality of treatment for surgical conditions involving hard-to-heal wounds, thereby increasing patient and family confidence and satisfaction during hospital care.

DKD reported the application of PL Pro biological gel for burn treatment at the Le Huu Trac National Burn Hospital

On 22/04/2024, representatives of the DKD Institute for Research & Application of Biological Excipients delivered a thematic presentation at the Le Huu Trac National Burn Hospital, focusing on practical experience in using PL Pro biological gel for the care of deep burns, necrotic burns, and chronic non-healing ulcers. The event attracted a large number of physicians, nurses, and medical specialists from various departments, creating an open and clinically rich academic discussion.

Main contents of the report

Rather than following a purely theoretical presentation style, the DKD team chose an approach based on a series of real cases that had been monitored and documented in clinical settings. The presented cases included:

Second- and third-degree burns with extensive tissue damage;
Necrotic tissue requiring infection control and proper drainage;
Persistent chronic ulcers with poor response to conventional regimens.

In all of these cases, PL Pro gel was applied topically as a key component of the care protocol. Follow-up data showed:

Rapid pain reduction;
Better infection control;
Stimulation of granulation tissue formation;
Accelerated re-epithelialization compared with initial expectations.

Notably, many cases did not require additional sedatives or systemic pain relief, thereby reducing the overall treatment burden for patients.

Clinical observations over 7–10 days

Through wound progression photographs and follow-up indicators over 7–10 days, the healthcare team at the session highly appreciated:

Clear improvement in tissue recovery (granulation and epithelialization);
Better control of wound exudate and odor;
Improved patient comfort and better adherence to care.

Many opinions also emphasized the biological safety of the gel and its applicability in situations where skin grafting is not possible, or when corticosteroids are contraindicated, thus “opening the door” to less invasive treatment strategies while still ensuring infection control and wound-healing promotion.

In-depth discussion & application orientation

The discussion session received many practical questions from physicians regarding:

How to combine PL Pro gel with dressings, cleansing, and necrotic tissue debridement;
Management in special areas (face, neck, hands, lower legs) and in severe infection settings;
Post-surgical follow-up and criteria for evaluating progress in order to optimize the next steps of care.

DKD representatives shared recommendations on application protocols, methods for standardizing clinical documentation, and key safety considerations at each stage. Both sides agreed to view the meeting as a bridge between applied research and clinical practice, while opening prospects for deeper collaboration in the near future.

DKD attended ISBI/BBA 2024
A global gateway for Vietnam’s wound-healing solutions

Birmingham (United Kingdom), 18–22/08/2024 – DKD’s founder and colleagues were the only representatives from Vietnam attending the ISBI/BBA 2024 Conference, an event bringing together more than 1,000 leading global experts in burn care and tissue regeneration. The conference aimed to share knowledge and promote humane, sustainable, and advanced treatment solutions for patient communities worldwide.

Highlights from DKD’s journey

Presenting clinical outcomes: DKD introduced a series of cases involving deep burns, tissue necrosis, and EB treated with PD.Curcumin biological gel, emphasizing a minimally invasive approach that in many cases did not require antibiotics or sedatives.
Deep academic connections: DKD worked directly with professors and research groups from the U.S., U.K., France, Japan, and others, expanding its collaborative network.
A distinct strategy: DKD made a strong impression with its commitment to Vietnamese biopharmaceutical innovation and its human-centered philosophy.

Ms. Kim Dung (center) – DKD Founder and Professor Folke Sjöberg (left) – President of the International Society for Burn Injuries (ISBI) at the conference gala dinner.

Opportunities opened after the conference

International collaboration with burn centers, institutes, and medical teams seeking non-invasive wound-healing solutions.
Orientation toward multicenter research across Europe, the U.S., and Southeast Asia.
Reinforcing the belief that inventions from Vietnam can reach the world when grounded in rigorous, ethical, and humane science.

Ms. Kim Dung (left) and Mr. Michael Serghiou (right) – Chief Executive of ISBI at the conference gala dinner.

“We are not searching for a new solution for the world; we are bringing a solution that has already proven effective for real people in real circumstances in Vietnam — and from there, contributing to rewriting global treatment standards.” – DKD Founder

The significance of ISBI/BBA for DKD

ISBI/BBA is a major forum for comparing clinical data, challenging scientific hypotheses, and updating treatment approaches according to international standards. For DKD, it represented a step forward in transforming practical experience into formal research collaboration, thereby narrowing the distance between laboratory, clinic, and community.

NEWS

DKD participated in the CRS BioBarriers conference and presented an international research poster

DKD Founder was honored among the Top 5 Inventive Authors at the IPSTAR 2025 program

DKD’s burn treatment product applied for children: A physician from Children’s Hospital 1 shared real clinical cases at the National Scientific Conference

DKD introduced the SUV Liposome biological membrane – PL Pro at the workshop “Care for hard-to-heal wounds” in Khanh Hoa

DKD attended ISBI/BBA 2024 A global gateway for Vietnam’s wound-healing solutions

DKD published its first scientific paper: Nanocurcumin liposome & PL Pro promote healing of burns and skin ulcers

DKD reported the application of PL Pro biological gel for burn treatment at the Le Huu Trac National Burn Hospital

DKD Founder was honored among the Top 5 Inventive Authors
at the IPSTAR 2025 program

DKD’s burn treatment product applied for children:
A physician from Children’s Hospital 1 shared real clinical cases at the National Scientific Conference

DKD attended ISBI/BBA 2024
A global gateway for Vietnam’s wound-healing solutions

DKD published its first scientific paper:
Nanocurcumin liposome & PL Pro promote healing of burns and skin ulcers